Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis [5]

Journal of Investigative Dermatology

Volumn 126, Issue 9, 2006, Pages 2141-2144

  Hoetzenecker, Wolfram ^a   Meindl, Simone ^a   Stuetz, Anton ^b   Stingl, Georg ^a   Elbe Bürger, Adelheid ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b Novartis Institutes for BioMedical Research Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CORTICOSTEROID; PIMECROLIMUS; TACROLIMUS;

APOPTOSIS; ATOPIC DERMATITIS; CELL VIABILITY; CLINICAL FEATURE; CLINICAL TRIAL; DENDRITIC CELL; DRUG MECHANISM; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SKIN ATROPHY; SKIN INFLAMMATION;

ADRENAL CORTEX HORMONES; DENDRITIC CELLS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; TACROLIMUS;

EID: 33747378525     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700368     Document Type: Letter

References (21)

1. Abe M, Thomson AW (2006) Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin Immunol 118:300-6
2. Bangert C, Friedl J, Stary G, Stingl G, Kopp T (2003) Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J Invest Dermatol 121:1409-18
3. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A et al. (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919-23
4. Grassberger M, Baumruker T, Enz A, Hiestand P, Hultsch T, Kalthoff F et al. (1999) A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 141:264-73
5. Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 92:44-7
6. + (myeloid) dendritic cells in atopic dermatitis. J Immunol 174:2396-403
7. Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Bürger A (2005) Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol 115:1276-83
8. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Bürger A (2004) Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 122:673-84
9. Kalthoff ES, Chung J, Musser P, Stuetz A (2003) Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol 133:350-9
10. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA (2004) New insights into atopic dermatitis. J Clin Invest 113:651-7
11. Luger T, van Leent EJM, Graeber M, Hedgecock S, Thurston M, Kandra A et al. (2001) SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 144:788-94
12. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-60
13. Rajka G, Langeland T (1989) Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144:13-4
14. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K et al. (2005) Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174:8003-10
15. Ruzicka T, Bieber T, Schöpf E et al. (1997) A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337:816-21
16. Shodell M, Shah K, Siegal FP (2003) Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus 12:222-30
17. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835-7
18. Stary G, Bangert C, Stingl G, Kopp T (2005) Dendritic cells in atopic dermatitis: expression of FcεRI on two distinct inflammation-associated subsets. Int Arch Allergy Immunol 138:278-90
19. Stoppolino G, Prisco F, Santinelli R, Sicuranza G, Giordano C (1983) Potential hazards of topical steroid therapy. Am J Dis Child 137:1130-1
20. Suda T, Chida K, Matsuda H, Hashizume H, Ide K, Yokomura K et al. (2003) High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells. J Allergy Clin Immunol 112:1237-9
21. Wollenberg A, Wagner M, Günther S, Towarowski A, Tuma E, Moderer M et al. (2002) Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119:1096-102